Selecting the Best Donor for Haploidentical Transplant: Impact of HLA, KIR Genotyping, and Other Clinical Variables

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2018.01.013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Selecting the Best Haploidentical Donor

Seminars in Hematology
Hematology
2016English

“No Donor”? Consider a Haploidentical Transplant

Blood Reviews
OncologyHematology
2015English

The Impact of Donor KIR and Patient HLA-C Genotypes on Outcome Following HLA-identical Sibling Hematopoietic Stem Cell Transplantation for Myeloid Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2004English

Impact of KIR/HLA Incompatibilities on NK Cell Reconstitution and Clinical Outcome After T Cell–Replete Haploidentical Hematopoietic Stem Cell Transplantation With Posttransplant Cyclophosphamide

Journal of Immunology
AllergyImmunology
2019English

Survival After T-Cell Replete Haploidentical Related Donor Hematopoietic Cell Transplantation (Haplo-Hct) Using Post-Transplant Cyclophosphamide (PT-CY) Compared With HLA-Matched Related Donor (MRD) Transplant for Lymphomas

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

The Impact of Graft Composition on Clinical Outcomes in Unmanipulated HLA-mismatched/haploidentical Hematopoietic SCT

Bone Marrow Transplantation
TransplantationHematology
2008English

Who Is the Best Haploidentical Donor for Acquired Severe Aplastic Anemia? Experience From a Multicenter Study

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Combination Treatment of Rituximab and Donor Platelets Infusion to Reduce Donor-Specific Anti-Hla Antibodies for Stem Cells Engraftment in Haploidentical Transplantation

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2020English

Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect Against Relapse After Myeloablative, HLA Matched Hematopoietic Cell Transplantation

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy